Patents by Inventor Gerhard Maass

Gerhard Maass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7001765
    Abstract: The present invention provides an Adeno-Associated Virus (AAV) vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: February 21, 2006
    Assignee: Medigene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Patent number: 6838272
    Abstract: The invention relates to a process for separating viruses of different sizes, with the virus-containing solution preferably being filtered through one or more filter membranes.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: January 4, 2005
    Assignee: Switch Biotech AG
    Inventors: Christoph Bogedain, Gerhard Maass, Markus Hörer
  • Publication number: 20040161418
    Abstract: The present invention provides an Adeno-Associated Virus (AAV) vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Application
    Filed: October 16, 2003
    Publication date: August 19, 2004
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Publication number: 20030036088
    Abstract: The invention relates to a process for separating viruses of different sizes, with the virus-containing solution preferably being filtered through one or more filter membranes.
    Type: Application
    Filed: September 26, 2002
    Publication date: February 20, 2003
    Inventors: Christoph Bogedain, Gerhard Maass, Markus Horer
  • Publication number: 20020168385
    Abstract: The present invention provides an Adeno-Associated Virus (AAV) vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Application
    Filed: July 2, 2002
    Publication date: November 14, 2002
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Patent number: 6479273
    Abstract: The invention relates to a process for separating viruses of different sizes, with the virus-containing solution preferably being filtered through one or more filter membranes.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: November 12, 2002
    Assignee: MediGene Aktiengesellschaft
    Inventors: Christoph Bogedain, Gerhard Maass, Markus Hörer
  • Patent number: 6448074
    Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: October 9, 2000
    Date of Patent: September 10, 2002
    Assignee: MediGene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Patent number: 6171597
    Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: January 9, 2001
    Assignee: Medigene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain